Is PGx Having a Moment? Kristine Ashcraft, Invitae episode artwork

EPISODE · Nov 10, 2022 · 33 MIN

Is PGx Having a Moment? Kristine Ashcraft, Invitae

from Mendelspod Podcast · host Theral Timpson

Pharmacogenomic testing, or PGx, is considered low-hanging fruit, a no-brainer for the application of genetic testing in the clinic. And some may think it is small fruit. Not so, says today’s guest, Kristine Ashcraft."Currently we lose a life every two minutes in the United States to non-optimized medications,” says Kristine in today’s show. She has spent over twenty years working to see pharmacogenomic testing adopted into standard-of-care medicine. Kristine serves today as the Medical Affairs Director for PGx at the genetic testing company Invitae. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Episode metadata supplied by the publisher feed · Published Nov 10, 2022

Embed this episode

NOW PLAYING

Is PGx Having a Moment? Kristine Ashcraft, Invitae

0:00 33:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mendelspod Podcast?

This episode is 33 minutes long.

When was this Mendelspod Podcast episode published?

This episode was published on November 10, 2022.

Can I download this Mendelspod Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!